Complex Regional Pain Syndrome
Conditions
Brief summary
Difference between groups (placebo vs. active treatment) in the change in self-reported daily ratings of mean average daily pain intensity (ADP) in the affected limb from the baseline week to the last week of treatment, as experienced during the past 24 hours, rated on a 0–10-point numeric rating scale (NRS; 0 = no pain, 10 = worst possible pain).
Detailed description
Difference in Pain relief on a 6-point scale: complete, good, moderate, mild, none, worse., Difference in the change in mean CRPS severity score (CSS) from end of baseline to end of week 4 and 8., Differences in the area and intensity of mechanical allodynia, assessed by brushing a soft brush (Somedic) twice with a speed of 1-2 cm/s, The relationship between the primary outcome measure and the duration of CRPS (measured in months).
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference between groups (placebo vs. active treatment) in the change in self-reported daily ratings of mean average daily pain intensity (ADP) in the affected limb from the baseline week to the last week of treatment, as experienced during the past 24 hours, rated on a 0–10-point numeric rating scale (NRS; 0 = no pain, 10 = worst possible pain). | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in Pain relief on a 6-point scale: complete, good, moderate, mild, none, worse., Difference in the change in mean CRPS severity score (CSS) from end of baseline to end of week 4 and 8., Differences in the area and intensity of mechanical allodynia, assessed by brushing a soft brush (Somedic) twice with a speed of 1-2 cm/s, The relationship between the primary outcome measure and the duration of CRPS (measured in months). | — |
Countries
Denmark